human immunodeficiency virus
Showing 1 - 25 of 281
Alcohol Use Disorder, Human Immunodeficiency Virus Trial in Chicago (10 day prebiotic consumption)
Not yet recruiting
- Alcohol Use Disorder
- Human Immunodeficiency Virus
- 10 day prebiotic consumption
-
Chicago, IllinoisAli Keshavarzian
Nov 14, 2023
Human Immunodeficiency Virus Trial in Winston-Salem (Navigators (peer navigator) training, delayed-intervention)
Not yet recruiting
- Human Immunodeficiency Virus
- Navigators (peer navigator) training
- delayed-intervention
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Nov 14, 2023
Gut Microbiome in People Living With HIV and HBV
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- (no location specified)
Nov 8, 2023
Human Immunodeficiency Virus, Mental Disorder Trial in Nairobi (Collaborative Care Model)
Not yet recruiting
- Human Immunodeficiency Virus
- Mental Disorder
- Collaborative Care Model
-
Nairobi, KenyaKenya Medical Research Institute
Nov 6, 2023
Human Immunodeficiency Virus, HIV Trial in Congella (In-person adolescent-friendly service (iPAS) intervention, mHealth (InTSHA)
Not yet recruiting
- Human Immunodeficiency Virus
- HIV
- In-person adolescent-friendly service (iPAS) intervention
- +2 more
-
Congella, South AfricaKing Edward VIII Hospital
Sep 6, 2023
Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)
Recruiting
- Human Immunodeficiency Virus
- Opioid Use Disorder
- Combined LAI Treatment: Cabenuva and Sublocade
-
Providence, Rhode IslandRhode Island Hospital
Aug 7, 2023
Human Immunodeficiency Virus, Alcohol-Related Disorders, Drug Use Trial in Cape Town (Khanya)
Recruiting
- Human Immunodeficiency Virus
- +3 more
- Khanya
-
Cape Town, Western Cape, South AfricaUniversity of Cape Town
Jul 7, 2023
Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)
Recruiting
- Human Immunodeficiency Virus
- +2 more
-
Seattle, WashingtonUW Positve Research, Harborview Medical Center
May 8, 2023
Human Immunodeficiency Virus Trial in Nairobi (In-Person Program Management Plus (PM+), Mobile Program Management Plus (mHealth
Not yet recruiting
- Human Immunodeficiency Virus
- In-Person Program Management Plus (PM+)
- Mobile Program Management Plus (mHealth PM+)
-
Nairobi, KenyaKenya Medical Research Institute
Apr 21, 2023
Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco Trial in Boston, Chennai (Varenicline, Positively Smoke Free
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- Varenicline
- +2 more
-
Boston, Massachusetts
- +1 more
Mar 13, 2023
Human Immunodeficiency Virus Trial run by the CC (Placebo, Pembrolizumab)
Recruiting
- Human Immunodeficiency Virus
- Placebo
- Pembrolizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
HIV, Human Immunodeficiency Virus, Cardiovascular Diseases Trial in San Francisco (Digital Educational Messaging)
Not yet recruiting
- HIV
- +3 more
- Digital Educational Messaging
-
San Francisco, CaliforniaUniversity of California San Francisco
Feb 1, 2023
Positive Attitudes Concerning Infant Feeding-Questionnaire for
Completed
- Human Immunodeficiency Virus
- Questionnaire
-
Brighton, United Kingdom
- +9 more
May 5, 2022
Transgender Health, Gender Dysphoria, Transgender Women Trial in Philadelphia (Doravirine/Lamivudine/Tenofovir, Spironolactone
Completed
- Transgender Health
- +3 more
- Doravirine/Lamivudine/Tenofovir
- +3 more
-
Philadelphia, PennsylvaniaClinical Research Unit at Thomas Jefferson University
Feb 1, 2023
Human Immunodeficiency Virus, HPV Infection, CIN 2/3 Trial in Kisumu (Thermocoagulation)
Completed
- Human Immunodeficiency Virus
- +2 more
- Thermocoagulation
-
Kisumu, KenyaKenya Medical Research Institute
Jan 5, 2023
Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet
Recruiting
- Tuberculosis
- +2 more
- Observational PK study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Dec 21, 2022
Human Immunodeficiency Virus Trial in Kisumu (Provision of multiple self-tests)
Completed
- Human Immunodeficiency Virus
- Provision of multiple self-tests
-
Kisumu, KenyaImpact Research and Development Organization
Nov 21, 2022
Human Immunodeficiency Virus, Human Immunodeficiency Virus Transmission, Sexually Transmitted Diseases Trial in Jacksonville
Recruiting
- Human Immunodeficiency Virus
- +2 more
- Clinic-wide Trainings
- +2 more
-
Jacksonville, FloridaFlorida Department of Health, Duval County
Dec 6, 2022
Cervical Cancer, CIN2, CIN3 Trial in Westdene (5 Fluorouracil (5 FU) Cream, Placebo)
Not yet recruiting
- Cervical Cancer
- +4 more
- 5 Fluorouracil (5 FU) Cream
- Placebo
-
Westdene, Johannesburg, South AfricaClinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
Nov 30, 2022
Human Immunodeficiency Virus Trial in Dengkil (PREM-Kit)
Not yet recruiting
- Human Immunodeficiency Virus
- PREM-Kit
-
Dengkil, Selangor, MalaysiaUniversiti Teknologi MARA (Dengkil Campus)
Nov 13, 2022
Human Immunodeficiency Virus Trial in Pietermaritzburg (START Together)
Active, not recruiting
- Human Immunodeficiency Virus
- START Together
-
Pietermaritzburg, KwaZulu-Natal, South AfricaHuman Sciences Research Council
Nov 9, 2022
Human Immunodeficiency Virus Trial in Birmingham, Cleveland, Pittsburgh (Dapivirine Vaginal Ring, Placebo Vaginal Ring)
Completed
- Human Immunodeficiency Virus
- Dapivirine Vaginal Ring
- Placebo Vaginal Ring
-
Birmingham, Alabama
- +2 more
Nov 2, 2022
Human Immunodeficiency Virus, Hepatitis C, Alcohol Abuse Trial in New York, Saint Petersburg (Computer-based alcohol reduction
Completed
- Human Immunodeficiency Virus
- +2 more
- Computer-based alcohol reduction intervention
- +2 more
-
New York, New York
- +1 more
Oct 31, 2022
Continuum for Youth at HIV Risk, Acutely Infected and With
Active, not recruiting
- Human Immunodeficiency Virus
-
Los Angeles, California
- +2 more
Oct 24, 2022
Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)
Not yet recruiting
- Human Immunodeficiency Virus
- HIV
- Islatravir
- Placebo
- (no location specified)
Oct 13, 2022